UBE2CP3

Across TCGA pan-cancer cohorts, UBE2CP3 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated UBE2CP3 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher UBE2CP3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated UBE2CP3 expression acts as an unfavorable survival marker, although some lineages such as LAML and BRCA show a favorable association.

UVM, TGCT, and ACC are the cancer types where UBE2CP3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	III,IV	0.088	0.691	<.001	63	view →
TGCT	OS	Tertile	All	0.862	0.989	.005	54	view →
ACC	OS	Tertile	II,III,IV	0.107	0.709	<.001	27	view →
UCS	OS	Median	II,III,IV	0.211	0.527	.013	26	view →
THYM	DFS	Tertile	All	0.783	0.930	.005	24	view →
LAML	DFS	Quartile	All	0.678	0.173	<.001	24	view →
UCEC	OS	Quartile	All	0.809	0.898	.004	22	view →
STAD	OS	Median	All	0.409	0.615	.008	14	view →
BRCA	OS	Quartile	III,IV	0.924	0.796	.006	13	view →
SARC	OS	Quartile	All	0.901	0.814	.010	10	view →
ESCA	OS	Median	All	0.414	0.572	.018	9	view →
LUSC	DFS	Quartile	II,III,IV	0.292	0.632	.013	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

UBE2CP3–UVM (DFS)

Open the UVM breakdown →